AU Patent

AU2017204505B2 — Controlled release enteric soft capsules of fumarate esters

Assigned to Banner Life Sciences LLC · Expires 2018-08-02 · 8y expired

What this patent protects

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof In particular, oral pharmaceutical compositions comprising controlled release enteric soft capsules and matrices comprising …

USPTO Abstract

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof In particular, oral pharmaceutical compositions comprising controlled release enteric soft capsules and matrices comprising fumarate esters are described. Release Profile 1 Release Profile 2 60 - Release Profile 3 -. ,50 pH 1.2 pH 6.8 0 60 120 180 240 300 360 420 480 540 600 660 Time (min)

Drugs covered by this patent

Patent Metadata

Patent number
AU2017204505B2
Jurisdiction
AU
Classification
—
Expires
2018-08-02
Drug substance claim
No
Drug product claim
No
Assignee
Banner Life Sciences LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.